Digital Therapeutics Global Market Report 2023: Sector to Reach $ 35.7 Billion by 2027 at a 25.6 % CAGR

Digital Therapeutics Global Market Report 2023: Sector to Reach $ 35.7 Billion by 2027 at a 25.6 % CAGR

The Global Digital Therapeutics market research report 2023 provides an in-depth analysis of an industry or market, covering essential aspects such as market size, growth potential, competitive landscape, consumer behaviour, and other significant factors influencing the market.

Request For Free PDF Before its Gone @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724

This report is a valuable resource for businesses seeking to enter or expand their presence in the market, as it enables them to make informed strategic decisions. Ultimately, the Digital Therapeutics market research report is a powerful tool for comprehending market dynamics and identifying opportunities for growth.

According to the new market research report "Digital Therapeutics Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel B2C (Patient, Caregiver), B2B ( Providers, Payer, Employer, Pharma) - Global Forecasts to 2027", The global digital therapeutics market is projected to reach USD 17.7 billion by 2027 from USD 4.5 billion in 2022, at a CAGR of 31.6% during the forecast period. View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/digital-therapeutics-market-51646724.html

The digital therapeutics market is mainly driven by factors such as increasing investments in digital therapeutics, rising incidence of preventable chronic diseases, increasing government initiatives to support technological developments, and developments in the field of digital therapeutics to curb growing healthcare costs. However, hesitancy among patients to adopt digital therapeutics, and uneven payment models are challenging the growth of this market.

North America is expected to hold the largest share of the digital therapeutics market

The digital therapeutics market has been segmented into four main regional segments: North America, Europe, the Asia Pacific, and Rest of the World. North America is expected to hold the largest share of this market, followed by Europe in 2022. The market in North America is also expected to grow at the highest CAGR. The large share can be attributed to the rising number of new start-ups in digital therapeutics market and slowly developing reimbursement structures for digital therapeutics solutions.

Key Market Players

Prominent players in the digital therapeutics market include Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Pear Therapeutics, Inc. (US), CogniFit Inc (US), Ginger (US), Propeller Health (US), 2Morrow, Inc. (US), Canary Health (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Twill Inc. (US), Better Therapeutics, Inc (US), Mindstrong (US), Kaia Health (Germany), BehaVR Inc (US), Ayogo (Canada), Mindable Health GmbH (Germany), Virta Health Corp (US), Hinge Health, Inc. (US), Orexo AB (Sweden) and Freespira (US).

Report Objectives

  • To define, describe, and forecast the digital therapeutics market based on sales channel, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall digital therapeutics market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)2
  • To profile key players and analyze their market shares and core competencies3
  • To track and analyze competitive developments such as product launches, partnerships, agreements, expansions, mergers, and acquisitions in the digital therapeutics market

Interested to Procure the Data? Inquire here at @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=51646724

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441


Priya Shinde

84 Blog posts

Comments